RxDoctor Payments Data

Cassie Wellock, PA

Physician Assistant · Reno, NVNPI 1720327869

Payments from drug & device makers

$1,853in general payments, 2019–2025

Across 106 payments — averaging $17.48 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • AbbVie$500
  • Novo Nordisk$212
  • AstraZeneca$151
  • Pfizer$133
  • GSK$109
  • Idorsia Pharmaceuticals US Inc$103
  • plus $646 from 14 others

What the payments were for

  • Food & beverage$1,853100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$1,853 in reported general payments places this provider in the 75th percentile of 881 physician assistant providers in Nevada.

See all physician assistant providers in Nevada

Medicare billing

Part B allowed, 2024
$30,788
Medicare patients
112
Services billed
329

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
OzempicSemaglutide22$32,693
TrulicityDulaglutide19$26,216
MounjaroTirzepatide22$25,257
Spiriva RespimatTiotropium Bromide12$7,070
BrilintaTicagrelor11$6,547
Rosuvastatin Calcium110$2,591
Albuterol Sulfate HfaAlbuterol Sulfate66$1,952
Lantus SolostarInsulin Glargine,hum.Rec.Anlog14$1,821
Atorvastatin Calcium143$1,730
Losartan Potassium83$1,377
Gabapentin36$1,312
Levothyroxine Sodium102$1,128
Alendronate Sodium47$993
Omeprazole67$841
Pantoprazole Sodium18$757

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
Lilly USA, LLCTrulicity, Mounjaro$74$51,47441 claims
Novo NordiskOzempic$212$32,69322 claims
Boehringer IngelheimSpiriva Respimat$86$7,07012 claims
AstraZenecaBrilinta$151$6,54711 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 75th percentile of 881 physician assistant providers in Nevada.

Other physician assistant in Reno

See the full list for Nevada

Where these figures come from

Is this you, or does something look wrong? →